Skip to content
Markets News
Earnings1 min read

Dexcom Posts 11% Sales Growth and Announces $1 Billion Buyback

Makkler Newsroom
October 30, 2026 · Based on reporting by finanzen.net

Dexcom reported higher third-quarter revenue and adjusted earnings, while raising its full-year sales outlook to $5.20 billion to $5.25 billion.

Key takeaways

  • Third-quarter revenue rose 11% year over year to $1.34 billion.
  • Dexcom announced a $1 billion share repurchase program and updated its annual revenue outlook.

Dexcom reported third-quarter revenue of $1.34 billion, up 11% year over year, and announced a new $1 billion share repurchase program. Adjusted earnings per share were $0.73, above market expectations, according to finanzen.net.

Adjusted operating income reached $339.5 million, equal to a 25.3% margin. The company updated its full-year revenue forecast to $5.20 billion to $5.25 billion.

Dexcom said new patient starts reached a record in the quarter, with the largest increase among people with Type 2 diabetes who do not use insulin. As of 20:00 UTC Friday, shares traded at $82.29, up 2.95% since the previous close.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.